Literature DB >> 26805015

Nonalcoholic fatty future disease.

Stergios A Polyzos1, Christos S Mantzoros2.   

Abstract

Entities:  

Keywords:  Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Noninvasive indices; Simple steatosis; Treatment

Mesh：

Year:  2015        PMID： 26805015     DOI： 10.1016/j.metabol.2015.12.009

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  14 in total

Review 1.  The intriguing connections of leptin to hyperparathyroidism.

Authors:  Stergios A Polyzos; Leonidas Duntas; Jens Bollerslev
Journal:  Endocrine       Date:  2017-07-20       Impact factor: 3.633

Review 2.  Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

Authors:  Stavroula A Paschou; Stergios A Polyzos; Panagiotis Anagnostis; Dimitrios G Goulis; Christina Kanaka-Gantenbein; Irene Lambrinoudaki; Neoklis A Georgopoulos; Andromachi Vryonidou
Journal:  Endocrine       Date:  2019-09-19       Impact factor: 3.633

3.  Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.

Authors:  Stergios A Polyzos; Nikolaos Perakakis; Chrysoula Boutari; Jannis Kountouras; Wael Ghaly; Athanasios D Anastasilakis; Asterios Karagiannis; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

Review 4.  Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease.

Authors:  Stergios A Polyzos; Dimitrios G Goulis; Olga Giouleme; Georgios S Germanidis; Antonis Goulas
Journal:  Curr Obes Rep       Date:  2022-05-02

Review 5.  Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones.

Authors:  K Pafili; S A Paschou; E Armeni; S A Polyzos; D G Goulis; I Lambrinoudaki
Journal:  J Endocrinol Invest       Date:  2022-03-18       Impact factor: 5.467

6.  Activin A and follistatin in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Athanasios D Anastasilakis; Georgios Α Triantafyllou; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-07-25       Impact factor: 8.694

7.  Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD).

Authors:  Stergios A Polyzos; Christos S Mantzoros
Journal:  Metabolism       Date:  2020-07-21       Impact factor: 8.694

8.  Relationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: Korea National Health and Nutrition Examination Survey, 2007-2010.

Authors:  Sung Woo Moon; Song Yee Kim; Ji Ye Jung; Young Ae Kang; Moo Suk Park; Young Sam Kim; Joon Chang; Jun Soo Ro; Yong-Ho Lee; Sang Hoon Lee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-08-28

Review 9.  Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease.

Authors:  Chrysoula Boutari; Nikolaos Perakakis; Christos Socrates Mantzoros
Journal:  Endocrinol Metab (Seoul)       Date:  2018-03

10.  Prevalence of asymptomatic bronchiectasis and associations among the health screening population in South Korea.

Authors:  Soo Han Kim; Young Ju Jung; Myung-Su Ko; Sei Won Lee; Jae Seung Lee; Yeon-Mok Oh
Journal:  ERJ Open Res       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.